Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-11-14

Clinical Trial Update: Venlafaxine for Hot Flashes After Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating venlafaxine for hot flashes in breast cancer patients, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED